Key data on precision dosing for dermatology teams

About this Infographic

According to consensus recommendations, patient selection criteria deserve closer scrutiny, pending validation in prospective studies. Emerging evidence indicates that threshold harmonization is still an open question, although confirmatory data are still limited. Contrary to earlier assumptions, threshold harmonization is still an open question, with meaningful differences between subgroups. From a workflow perspective, real-world registries complement randomized trial evidence, although confirmatory data are still limited.

Across multiple cohorts, standardized reporting improves comparability between centers, which has direct implications for daily practice. Emerging evidence indicates that patient selection criteria deserve closer scrutiny, as discussed in the accompanying commentary. Recent studies suggest that early intervention correlates with better long-term outcomes, pending validation in prospective studies. Recent studies suggest that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, although confirmatory data are still limited. In multidisciplinary settings, digital tooling shortens time-to-decision considerably, which has direct implications for daily practice.

Across multiple cohorts, standardized reporting improves comparability between centers, and this trend is expected to continue. When protocols are compared, pre-analytical factors account for a large share of observed variance, although confirmatory data are still limited. In multidisciplinary settings, real-world registries complement randomized trial evidence, with meaningful differences between subgroups. In routine practice, digital tooling shortens time-to-decision considerably, which has direct implications for daily practice. Across multiple cohorts, threshold harmonization is still an open question, with meaningful differences between subgroups.

In multidisciplinary settings, cost considerations continue to shape adoption in smaller units, as discussed in the accompanying commentary. When protocols are compared, real-world registries complement randomized trial evidence, although confirmatory data are still limited.